Ciprofloxacin resistance in enterococcus faecalis strains isolated from male patients with complicated urinary tract infection

Korean Journal of Urology

Volumn 54, Issue 6, 2013, Pages 388-393

  Lee, Gilho ^a  

^a Dankook University College of Medicine   (South Korea)

Author keywords

Ciprofloxacin; Drug resistance; Enterococcus faecalis; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; NORFLOXACIN; PENICILLIN G; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; ENTEROCOCCUS FAECALIS; HUMAN; LENGTH OF STAY; MALE; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; RISK FACTOR; URINARY TRACT INFECTION;

EID: 84879190094     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2013.54.6.388     Document Type: Article

References (31)

1. Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, et al. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents 2011;38 Suppl:64-70.
2. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol 2009;19:368-74.
3. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-123.
4. Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am 2008;35:13-22
5. Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med 2013;173:62-68.
6. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician 1999;59:1225-1234, 1237.
7. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-1334.
8. Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res 2008;128:111-121.
9. Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, et al. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents 2011;37:210-218.
10. Lee SJ, Lee DS, Choe HS, Shim BS, Kim CS, Kim ME, et al. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother 2011;17:440-446.
11. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239-249.
12. Yasufuku T, Shigemura K, Shirakawa T, Matsumoto M, Nakano Y, Tanaka K, et al. Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections. J Clin Microbiol 2011;49:3912-3916.
13. Lee G, Cho YH, Shim BS, Lee SD. Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study. J Korean Med Sci 2010;25:1205-1209.
14. Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, et al. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy. J Infect Chemother 2011;17: 126-138.
15. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-587.
16. Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta- lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 2012; 74:62-67.
17. Huang CC, Chen YS, Toh HS, Lee YL, Liu YM, Ho CM, et al. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010. Int J Antimicrob Agents 2012;40 Suppl: S4-S10.
18. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
19. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362:1804-13.
20. Sava IG, Heikens E, Huebner J. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 2010;16:533-40.
21. Sibel AK, Koroglu M, Muharrem AK. The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in eastern Turkey. Southeast Asian J Trop Med Public Health 2012;43:986-91.
22. Morrison AJ Jr, Wenzel RP. Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital. Arch Intern Med 1986;146:1549-51.
23. Adam D. Beta-lactam/beta-lactamase inhibitor combinations in empiric management of pediatric infections. J Int Med Res 2002;30 Suppl 1:10A-19A.
24. Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, et al. The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 2010;51:280-5.
25. Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, et al. Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection. Eur J Clin Microbiol Infect Dis 2012;31:423-430.
26. van der Starre WE, van Nieuwkoop C, Paltansing S, van't Wout JW, Groeneveld GH, Becker MJ, et al. Risk factors for fluoroquinolone- resistant Escherichia coli in adults with community- onset febrile urinary tract infection. J Antimicrob Chemother 2011;66:650-656.
27. Rattanaumpawan P, Tolomeo P, Bilker WB, Fishman NO, Lautenbach E. Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients. Epidemiol Infect 2011;139:955-61.
28. Roghmann MC, Wallin MT, Gorman PH, Johnson JA. Prevalence and natural history of colonization with fluoroquinolone-resistant gram-negative bacilli in community-dwelling people with spinal cord dysfunction. Arch Phys Med Rehabil 2006;87:1305-9.
29. Klare I, Konstabel C, Mueller-Bertling S, Werner G, Strommenger B, Kettlitz C, et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 2005;24:815-25.
30. Klare I, Konstabel C, Badstubner D, Werner G, Witte W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003;88:269-90.
31. Puhto T, Ylipalosaari P, Ohtonen P, Syrjala H. Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards. Infection 2011;39:217-23.